Bailard Inc. Sells 265 Shares of Cardinal Health, Inc. $CAH

Bailard Inc. trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,084 shares of the company’s stock after selling 265 shares during the quarter. Bailard Inc.’s holdings in Cardinal Health were worth $1,022,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Stephens Inc. AR grew its position in shares of Cardinal Health by 5.6% during the 1st quarter. Stephens Inc. AR now owns 6,195 shares of the company’s stock worth $853,000 after buying an additional 329 shares in the last quarter. Edgestream Partners L.P. raised its stake in shares of Cardinal Health by 118.8% during the 1st quarter. Edgestream Partners L.P. now owns 16,001 shares of the company’s stock worth $2,204,000 after acquiring an additional 8,688 shares in the last quarter. Apollon Wealth Management LLC increased its position in shares of Cardinal Health by 10.0% during the first quarter. Apollon Wealth Management LLC now owns 3,143 shares of the company’s stock worth $433,000 after purchasing an additional 286 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in Cardinal Health by 196.4% in the first quarter. Massachusetts Financial Services Co. MA now owns 18,320 shares of the company’s stock valued at $2,524,000 after buying an additional 12,140 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. raised its position in shares of Cardinal Health by 349.3% in the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 2,835 shares of the company’s stock valued at $391,000 after purchasing an additional 2,204 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Insider Buying and Selling at Cardinal Health

In related news, CEO Jason M. Hollar sold 35,901 shares of Cardinal Health stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the transaction, the chief executive officer owned 200,000 shares in the company, valued at approximately $30,008,000. The trade was a 15.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the sale, the chief executive officer directly owned 26,085 shares in the company, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 271,676 shares of company stock valued at $40,489,525. Corporate insiders own 0.12% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on CAH. Jefferies Financial Group set a $220.00 target price on Cardinal Health and gave the stock a “buy” rating in a research note on Monday, November 3rd. Citigroup raised their price target on shares of Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research report on Friday, October 31st. TD Cowen boosted their price objective on Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, November 3rd. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $205.00.

Cardinal Health Stock Performance

Cardinal Health stock opened at $205.94 on Friday. The company has a market capitalization of $48.93 billion, a PE ratio of 31.93, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72. Cardinal Health, Inc. has a fifty-two week low of $114.60 and a fifty-two week high of $207.47. The firm has a 50 day moving average price of $164.46 and a 200 day moving average price of $158.49.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping the consensus estimate of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company’s quarterly revenue was up 22.4% on a year-over-year basis. During the same period last year, the business posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio is currently 30.77%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.